1. Home
  2. RBA vs BBIO Comparison

RBA vs BBIO Comparison

Compare RBA & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RB Global Inc.

RBA

RB Global Inc.

HOLD

Current Price

$104.08

Market Cap

18.8B

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$65.62

Market Cap

15.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBA
BBIO
Founded
1958
2015
Country
United States
United States
Employees
7900
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.8B
15.3B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RBA
BBIO
Price
$104.08
$65.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
23
Target Price
$128.75
$82.26
AVG Volume (30 Days)
1.8M
3.1M
Earning Date
01-01-0001
05-22-2026
Dividend Yield
1.17%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$502,076,000.00
Revenue This Year
$4.56
$85.55
Revenue Next Year
$6.67
$71.10
P/E Ratio
$52.68
N/A
Revenue Growth
N/A
126.26
52 Week Low
$87.87
$28.33
52 Week High
$119.58
$84.94

Technical Indicators

Market Signals
Indicator
RBA
BBIO
Relative Strength Index (RSI) 47.65 39.11
Support Level $96.45 $61.54
Resistance Level $106.54 $68.71
Average True Range (ATR) 3.80 3.09
MACD 0.29 -0.28
Stochastic Oscillator 42.86 23.01

Price Performance

Historical Comparison
RBA
BBIO

About RBA RB Global Inc.

RB Global has evolved into a leading global marketplace that connects buyers and sellers of commercial assets and vehicles. It is the result of the 2023 combination of Ritchie Bros. and IAA. Ritchie Bros.' roots were as an auctioneer facilitating transactions of commercial, construction, and transportation equipment (excavators, bulldozers, forklifts, and commercial trucks and trailers). However, it has evolved into an omnichannel marketplace. IAA has similar roots, though primarily focused on the salvage auction segment for consumer automobiles. The group provides ancillary services including title processing, transportation/towing, financing, data and appraisal, and so on. Its activities are international, though skewing approximately two-thirds to North America.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: